- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Myeloma
Total 12364 results
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompletedMultiple Myeloma | Myeloma | M-Protein | Myeloma Proteins
-
The First Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Yonsei UniversityUnknownMultiple Myeloma Patients Who Candidate for Autologous Peripheral Blood Stem Cell TransplantationKorea, Republic of
-
Gilead SciencesCompletedMultiple Myeloma | Myeloma, Plasma-Cell | PLASMACYTOMAUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell MyelomaUnited States
-
University of Heidelberg Medical CenterGerman Cancer Research Center; University Hospital Heidelberg; Array BioPharma; Coordinating Centre for Clinical Trials HeidelbergActive, not recruitingRelapsed or Refractory Multiple Myeloma | Patients With BRAFV600 E or BRAFV600K MutationGermany
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedLeukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
SanofiNot yet recruiting
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationActive, not recruitingPlasma Cell Myeloma | Residual DiseaseUnited States
-
University of Colorado, DenverTerminatedRefractory Plasma Cell MyelomaUnited States
-
Masonic Cancer Center, University of MinnesotaMinnesota Medical FoundationTerminatedAcute Myeloid Leukemia | Myeloproliferative Disorders | Multiple Myeloma | Hodgkin Disease | Non-Hodgkin LymphomaUnited States
-
Nanjing IASO Biotechnology Co., Ltd.Ruijin HospitalRecruitingPlasma Cell Leukemia | Relapsed/Refractory Multiple MyelomaChina
-
Chunrui LiNanjing IASO Biotechnology Co., LtdRecruitingPlasma Cell Leukemia | Relapsed/Refractory Multiple MyelomaChina
-
Array Biopharma, now a wholly owned subsidiary...CompletedMultiple Myeloma, Plasma Cell LeukemiaUnited States
-
University of RochesterRecruitingMultiple Myeloma | Prostate Cancer | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma (SMM)United States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingPlasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterActive, not recruitingPlasma Cell Myeloma | Transplant-Related CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
Technische Universität DresdenGerman Cancer Research CenterRecruitingNeoplasms | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)Germany
-
Hellenic Society of HematologyGlaxoSmithKlineNot yet recruitingNeoplasms | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Multiple Myeloma in Relapse | Gammopathy, Monoclonal | Haematologic Disease
-
Hangzhou Sumgen Biotech Co., Ltd.Active, not recruitingRelapsed or Refractory Multiple Myeloma | Hematological MalignancyChina
-
TakedaCompletedRelapse and/or Refractory Multiple MyelomaPortugal
-
Intergroupe Francophone du MyelomeBristol-Myers Squibb; Takeda; University Hospital, Grenoble; Nantes University... and other collaboratorsTerminatedMultiple Myeloma | Genetic Condition | Relapsed and Refractory Multiple MyelomaFrance
-
Nantes University HospitalActive, not recruitingMultiple Myeloma at First RelapseFrance
-
Dana-Farber Cancer InstituteNovartisCompletedMultiple Myeloma in RelapseUnited States
-
CTI BioPharmaNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompletedInfection | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jan WalewskiCompletedLymphoma | Multiple Myeloma and Plasma Cell NeoplasmPoland
-
Genesis Pharma S.A.Completed
-
University of MiamiNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Lithuanian University of Health SciencesUnknownMultiple Myeloma and Malignant Plasma Cell NeoplasmsLithuania
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Meir Medical CenterUnknown
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
SanofiRecruitingPlasma Cell Myeloma RefractoryFrance, Australia, Greece, Italy, Norway, United States, Portugal, Puerto Rico, Germany
-
Thomas Jefferson UniversityCompletedPlasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | t(11;14) Negative
-
Our Lady of Mercy Medical CenterUnknownLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Ontario Clinical Oncology Group (OCOG)PfizerNot yet recruitingRefractory Multiple MyelomaCanada
-
Fu chengcheng PhDNot yet recruitingMultiple Myeloma at First Relapse
-
International Myeloma FoundationJanssen Scientific Affairs, LLC; Celgene; Amgen; Trevie, Inc.Active, not recruitingSmoldering Multiple MyelomaUnited States
-
Assistance Publique - Hôpitaux de ParisActive, not recruiting
-
Institut Cancerologie de l'OuestTerminatedMultiple Myeloma in RelapseFrance
-
Multinational Center for Quality of Life Research...Unknown
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPain | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States